Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
8 studies found for:    15383478 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Multiple Algorithms System Of All Scores in Embolism (MOSE)
Conditions: Venous Thromboembolism;   Risk Assessment;   Risk Management
2 Completed
Has Results
Toronto Thromboprophylaxis Patient Safety Initiative
Condition: Venous Thromboembolism
Intervention: Other: Knowledge Translation (KT) toolkit
3 Recruiting Norwegian Intensive Care Unit Dalteparin Effect Study
Conditions: Acute Kidney Injury;   Deep Venous Thrombosis
Intervention: Device: Continuous venovenous hemodialysis
4 Terminated Anticoagulation Post Laparoscopic Splenectomy
Conditions: Portal Vein Thrombosis;   Splenic Vein Thrombosis
Intervention: Drug: Enoxaparin
5 Completed 3 Screen Electronic Alert
Conditions: Deep Vein Thrombosis;   Pulmonary Embolism;   Cancer
6 Completed
Has Results
The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients
Condition: Venous Thromboembolism
Interventions: Drug: fondaparinux sodium;   Device: sequential compression devices
7 Active, not recruiting PERIOP 2 - A Safety and Effectiveness Study of LMWH Bridging Therapy Versus Placebo Bridging Therapy for Patients on Long Term Warfarin and Require Temporary Interruption of Their Warfarin.
Condition: Stroke
Interventions: Drug: Dalteparin;   Other: Placebo
8 Completed The D-KAF (Dalteparin in Knee-to-Ankle Fracture) Trial
Conditions: Deep Vein Thrombosis;   Pulmonary Embolism
Intervention: Drug: Low Molecular Weight Heparin (dalteparin)

Indicates status has not been verified in more than two years